{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:54:49Z","timestamp":1793840089402,"version":"4.6.1"},"reference-count":232,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    CD4\n                    <jats:sup>+<\/jats:sup>\n                    CD25\n                    <jats:sup>+<\/jats:sup>\n                    Foxp3\n                    <jats:sup>+<\/jats:sup>\n                    regulatory T cells (Tregs), a vital component of the immune system, are responsible for maintaining immune homeostasis and preventing excessive immune responses. This review explores the signaling pathways of the cytokines that regulate Treg cells, including transforming growth factor beta (TGF-\u03b2), interleukin (IL)-2, IL-10, and IL-35, which foster the differentiation and enhance the immunosuppressive capabilities of Tregs. It also examines how, conversely, signals mediated by IL-6 and tumor necrosis factor -alpha (TNF-\u03b1) can undermine Treg suppressive functions or even drive their reprogramming into effector T cells. The B7 family comprises indispensable co-stimulators for T cell activation. Among its members, this review focuses on the capacity of CTLA-4 and PD-1 to regulate the differentiation, function, and survival of Tregs. As Tregs play an essential role in maintaining immune homeostasis, their dysfunction contributes to the pathogenesis of autoimmune diseases. This review delves into the potential of employing Treg-based immunotherapy for the treatment of autoimmune diseases, transplant rejection, and cancer. By shedding light on these topics, this article aims to enhance our understanding of the regulation of Tregs by cytokines and their therapeutic potential for various pathological conditions.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2024.1387975","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T08:17:59Z","timestamp":1715674679000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":203,"title":["Regulation of Treg cells by cytokine signaling and co-stimulatory molecules"],"prefix":"10.3389","volume":"15","author":[{"given":"Yuan","family":"Zong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaihang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Po","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing il-2 receptor alpha-chains (Cd25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/1471\u2013230X-12\u201397","article-title":"Deletion of foxp3+ Regulatory T cells in genetically targeted mice supports development of intestinal inflammation","volume":"12","author":"Boehm","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803646","article-title":"Regulatory T cell suppression is potentiated by target T cells in a cell contact, il-35- and il-10-dependent manner","volume":"182","author":"Collison","year":"2009","journal-title":"J Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.5.629","article-title":"Cell contact-dependent immunosuppression by cd4(+)Cd25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta","volume":"194","author":"Nakamura","year":"2001","journal-title":"J Exp Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/ni1536","article-title":"Cd4+Cd25+Foxp3+ Regulatory T cells induce cytokine deprivation-mediated apoptosis of effector cd4+ T cells","volume":"8","author":"Pandiyan","year":"2007","journal-title":"Nat Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2023739118","article-title":"Treg-expressed ctla-4 depletes cd80\/cd86 by trogocytosis, releasing free pd-L1 on antigen-presenting cells","volume":"118","author":"Tekguc","year":"2021","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001272","article-title":"Programmed cell death 1 ligand (Pd-L1) on T cells generates treg suppression from memory","volume":"19","author":"Kazanova","year":"2021","journal-title":"PloS Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.666531","article-title":"Inflammation determines the capacity of allogenic endothelial cells to regulate human treg expansion","volume":"12","author":"Cross","year":"2021","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.21037\/atm-20\u20136719","article-title":"The role of the programmed cell death protein-1\/programmed death-ligand 1 pathway, regulatory T cells and T helper 17 cells in tumor immunity: A narrative review","volume":"8","author":"Zhang","year":"2020","journal-title":"Ann Transl Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.cell.2017.05.005","article-title":"Interferon-gamma drives T(Reg) fragility to promote anti-tumor immunity","volume":"169","author":"Overacre-Delgoffe","year":"2017","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.14712\/18059694.2016.63","article-title":"Regulatory T cells (Treg) and their roles in immune system with respect to immunopathological disorders","volume":"53","author":"Kondelkova","year":"2010","journal-title":"Acta Med (Hradec Kralove)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.616949","article-title":"The complex role of regulatory T cells in immunity and aging","volume":"11","author":"Rocamora-Reverte","year":"2020","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00018\u2013009-0026\u20132","article-title":"The development and function of regulatory T cells","volume":"66","author":"Workman","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2017.65","article-title":"Antigen-specific regulatory T-cell responses to intestinal microbiota","volume":"10","author":"Russler-Germain","year":"2017","journal-title":"Mucosal Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral cd4+Cd25- naive T cells to cd4+Cd25+ Regulatory T cells by tgf-beta induction of transcription factor foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011\u201311-392324","article-title":"Functionally distinct subsets of human foxp3+ Treg cells that phenotypically mirror effector th cells","volume":"119","author":"Duhen","year":"2012","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.06.079","article-title":"An atlas of human regulatory T helper-like cells reveals features of th2-like tregs that support a tumorigenic environment","volume":"20","author":"Halim","year":"2017","journal-title":"Cell Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2426","article-title":"Follicular regulatory T cells expressing foxp3 and bcl-6 suppress germinal center reactions","volume":"17","author":"Chung","year":"2011","journal-title":"Nat Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1715","article-title":"Cytokine-secreting follicular T cells shape the antibody repertoire","volume":"10","author":"Reinhardt","year":"2009","journal-title":"Nat Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20170901","article-title":"Deficiency in T follicular regulatory cells promotes autoimmunity","volume":"215","author":"Fu","year":"2018","journal-title":"J Exp Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/imr.12160","article-title":"Ttregs, ptregs, and itregs: similarities and differences","volume":"259","author":"Shevach","year":"2014","journal-title":"Immunol Rev"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102964","article-title":"Expression of helios in peripherally induced foxp3+ Regulatory T cells","volume":"188","author":"Gottschalk","year":"2012","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1084\/jem.20120822","article-title":"Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo","volume":"209","author":"Yadav","year":"2012","journal-title":"J Exp Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011\u201309-377895","article-title":"Oligodeoxynucleotides stabilize helios-expressing foxp3+ Human T regulatory cells during in vitro expansion","volume":"119","author":"Kim","year":"2012","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/ni.1731","article-title":"The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation","volume":"10","author":"Koch","year":"2009","journal-title":"Nat Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00018\u2013017-2569-y","article-title":"Molecular mechanisms underlying th1-like treg generation and function","volume":"74","author":"Kitz","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2896","article-title":"Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma","volume":"18","author":"Krishnamoorthy","year":"2012","journal-title":"Nat Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.02.004","article-title":"Regulatory T cell reprogramming toward a th2-cell-like lineage impairs oral tolerance and promotes food allergy","volume":"42","author":"Noval Rivas","year":"2015","journal-title":"Immunity"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1403225","article-title":"Tr1 cells, but not foxp3+ Regulatory T cells, suppress nlrp3 inflammasome activation via an il-10-dependent mechanism","volume":"195","author":"Yao","year":"2015","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.671579","article-title":"Tr1 cells as a key regulator for maintaining immune homeostasis in transplantation","volume":"12","author":"Song","year":"2021","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100315","article-title":"Cutting edge: human regulatory T cells require il-35 to mediate suppression and infectious tolerance","volume":"186","author":"Chaturvedi","year":"2011","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/eji.201847935","article-title":"Helios(+) and helios(-) treg subpopulations are phenotypically and functionally distinct and express dissimilar tcr repertoires","volume":"49","author":"Thornton","year":"2019","journal-title":"Eur J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41423\u2013023-01036\u20137","article-title":"Intricacies of tgf-beta signaling in treg and th17 cell biology","volume":"20","author":"Wang","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.090936","article-title":"Control of th2-mediated inflammation by regulatory T cells","volume":"177","author":"Venuprasad","year":"2010","journal-title":"Am J Pathol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41590\u2013023-01453-w","article-title":"Ifngamma-induction of T(H)1-like regulatory T cells controls antiviral responses","volume":"24","author":"Gocher-Demske","year":"2023","journal-title":"Nat Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015020203","article-title":"Cxcr3+ Regulatory T cells control th1 responses in crescentic gn","volume":"27","author":"Paust","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.12703\/r\/10\u201330","article-title":"Recent advances in understanding the th1\/th2 effector choice","volume":"10","author":"Butcher","year":"2021","journal-title":"Fac Rev"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1209772","article-title":"Regulation of the T helper cell type 2 (Th2)\/T regulatory cell (Treg) balance by il-4 and stat6","volume":"87","author":"Chapoval","year":"2010","journal-title":"J Leukoc Biol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032713\u2013120257","article-title":"Tgf-beta activation and function in immunity","volume":"32","author":"Travis","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"a022061","DOI":"10.1101\/cshperspect.a022061","article-title":"Tgf-beta signaling from receptors to smads","volume":"8","author":"Hata","year":"2016","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2007.02.015","article-title":"Negative regulation of tgf-beta receptor\/smad signal transduction","volume":"19","author":"Itoh","year":"2007","journal-title":"Curr Opin Cell Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200106023","article-title":"The N domain of smad7 is essential for specific inhibition of transforming growth factor-beta signaling","volume":"155","author":"Hanyu","year":"2001","journal-title":"J Cell Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/72835","article-title":"A role for smad6 in development and homeostasis of the cardiovascular system","volume":"24","author":"Galvin","year":"2000","journal-title":"Nat Genet"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202350460","article-title":"Tgf-beta1 signaling and smad7 control T-cell responses in health and immune-mediated disorders","volume":"53","author":"Laudisi","year":"2023","journal-title":"Eur J Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/ijms19030730","article-title":"The balance of th17 versus treg cells in autoimmunity","volume":"19","author":"Lee","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2007.10.011","article-title":"Transcriptional regulation of th17 cell differentiation","volume":"19","author":"Ivanov","year":"2007","journal-title":"Semin Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","article-title":"Molecular antagonism and plasticity of regulatory and inflammatory T cell programs","volume":"29","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nature06878","article-title":"Tgf-beta-induced foxp3 inhibits T(H)17 cell differentiation by antagonizing rorgammat function","volume":"453","author":"Zhou","year":"2008","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/ni1549","article-title":"Smad3 and nfat cooperate to induce foxp3 expression through its enhancer","volume":"9","author":"Tone","year":"2008","journal-title":"Nat Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1108352109","article-title":"Requirements of transcription factor smad-dependent and -independent tgf-beta signaling to control discrete T-cell functions","volume":"109","author":"Gu","year":"2012","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000769","article-title":"Combined administration of a mutant tgf-beta1\/fc and rapamycin promotes induction of regulatory T cells and islet allograft tolerance","volume":"185","author":"Zhang","year":"2010","journal-title":"J Immunol"},{"key":"B52","article-title":"Inhibition of T and B lymphocyte proliferation by rapamycin","volume":"72","author":"Kay","year":"1991","journal-title":"Immunology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13075\u2013023-03181-w","article-title":"Mechanistic target of rapamycin (Mtor): A potential new therapeutic target for rheumatoid arthritis","volume":"25","author":"Zhang","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"B54","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neulet.2019.04.035","article-title":"Rapamycin relieves inflammation of experimental autoimmune encephalomyelitis by altering the balance of treg\/th17 in a mouse model","volume":"705","author":"Li","year":"2019","journal-title":"Neurosci Lett"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-cancerbio-070620\u2013103554","article-title":"Tgfbeta: signaling blockade for cancer immunotherapy","volume":"6","author":"Chen","year":"2022","journal-title":"Annu Rev Cancer Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2022.10.019","article-title":"The role of tgf-beta in the tumor microenvironment of pancreatic cancer","volume":"10","author":"Luo","year":"2023","journal-title":"Genes Dis"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s10528\u2013023-10591\u20137","article-title":"A novel tgf-beta-related signature for predicting prognosis, tumor microenvironment, and therapeutic response in colorectal cancer","author":"Tao","year":"2023","journal-title":"Biochem Genet"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/sj.embor.7401099","article-title":"Interleukin 2: from immunostimulation to immunoregulation and back again","volume":"8","author":"Bachmann","year":"2007","journal-title":"EMBO Rep"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aat1482","article-title":"Revisiting il-2: biology and therapeutic prospects","volume":"3","author":"Abbas","year":"2018","journal-title":"Sci Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.2056","article-title":"Essential biphasic role for jak3 catalytic activity in il-2 receptor signaling","volume":"12","author":"Smith","year":"2016","journal-title":"Nat Chem Biol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042617\u2013053352","article-title":"Signaling and function of interleukin-2 in T lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","article-title":"Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.07.031","article-title":"Control of the inheritance of regulatory T cell identity by a cis element in the foxp3 locus","volume":"158","author":"Feng","year":"2014","journal-title":"Cell"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.2337\/db14\u20131322","article-title":"Selective il-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose il-2 therapy in type 1 diabetes","volume":"64","author":"Yu","year":"2015","journal-title":"Diabetes"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2021.119192","article-title":"The role of a disintegrin and metalloproteinase (Adam)-10 in T helper cell biology","volume":"1869","author":"Sezin","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.62432","article-title":"Il-2\/jes6\u20131 mab complexes dramatically increase sensitivity to lps through ifn-gamma production by cd25(+)Foxp3(-) T cells","volume":"10","author":"Tomala","year":"2021","journal-title":"Elife"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.153072","article-title":"Il-2 promotes early treg reconstitution after allogeneic hematopoietic cell transplantation","volume":"102","author":"Betts","year":"2017","journal-title":"Haematologica"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-cell responses to low-dose interleukin-2 in hcv-induced vasculitis","volume":"365","author":"Saadoun","year":"2011","journal-title":"N Engl J Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S2213\u20138587(13)70113-X","article-title":"Low-dose interleukin 2 in patients with type 1 diabetes: A phase 1\/2 randomised, double-blind, placebo-controlled trial","volume":"1","author":"Hartemann","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018\u2013213036","article-title":"Short-term and low-dose il-2 therapy restores the th17\/treg balance in the peripheral blood of patients with primary Sjogren\u2019s syndrome","volume":"77","author":"Miao","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019\u2013216246","article-title":"Circulating regulatory T cells were absolutely decreased in dermatomyositis\/polymyositis patients and restored by low-dose il-2","volume":"80","author":"Zhang","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018\u2013214229","article-title":"Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial","volume":"78","author":"Rosenzwajg","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B73","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.23.16513","article-title":"Interleukin-10 receptor signaling through the jak-stat pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action","volume":"274","author":"Riley","year":"1999","journal-title":"J Biol Chem"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41375\u2013018-0117-x","article-title":"Implications of stat3 and stat5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer","volume":"32","author":"Wingelhofer","year":"2018","journal-title":"Leukemia"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1002\/eji.200526192","article-title":"Control of dual-specificity phosphatase-1 expression in activated macrophages by il-10","volume":"35","author":"Hammer","year":"2005","journal-title":"Eur J Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.1.292","article-title":"Posttranscriptional regulation of il-10 gene expression through sequences in the 3\u2019-untranslated region","volume":"165","author":"Powell","year":"2000","journal-title":"J Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2011.94","article-title":"Analysis of the host microrna response to salmonella uncovers the control of major cytokines by the let-7 family","volume":"30","author":"Schulte","year":"2011","journal-title":"EMBO J"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0808743106","article-title":"Posttranscriptional regulation of interleukin-10 expression by hsa-mir-106a","volume":"106","author":"Sharma","year":"2009","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000136","article-title":"Cutting edge: inhibition of glycogen synthase kinase 3 activity induces the generation and enhanced suppressive function of human il-10(+) foxp3(+)-induced regulatory T cells","volume":"205","author":"Cheng","year":"2020","journal-title":"J Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.im0327s113","article-title":"Differentiation and characterization of tr1 cells","volume":"113","author":"Chihara","year":"2016","journal-title":"Curr Protoc Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1912","article-title":"The aryl hydrocarbon receptor interacts with C-maf to promote the differentiation of type 1 regulatory T cells induced by il-27","volume":"11","author":"Apetoh","year":"2010","journal-title":"Nat Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"5457","DOI":"10.1038\/s41467\u2013018-07581\u20134","article-title":"Molecular and functional heterogeneity of il-10-producing cd4(+) T cells","volume":"9","author":"Brockmann","year":"2018","journal-title":"Nat Commun"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1007\/s10157\u2013012-0591\u20139","article-title":"Regulatory T-cell subset analysis and profile of interleukin (Il)-10, il-17 and interferon-gamma cytokine-producing cells in kidney allograft recipients with donor cells infusion","volume":"16","author":"Ranjbar","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1038\/s41467\u2013019-11338-y","article-title":"Long-term tolerance of islet allografts in nonhuman primates induced by apoptotic donor leukocytes","volume":"10","author":"Singh","year":"2019","journal-title":"Nat Commun"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001208","article-title":"Regulatory T cells promote alloengraftment in a model of late-gestation in utero hematopoietic cell transplantation","volume":"4","author":"Riley","year":"2020","journal-title":"Blood Adv"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/ni1540","article-title":"Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells","volume":"8","author":"Fitzgerald","year":"2007","journal-title":"Nat Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20141678","article-title":"Nk-dc crosstalk controls the autopathogenic th17 response through an innate ifn-gamma-il-27 axis","volume":"212","author":"Chong","year":"2015","journal-title":"J Exp Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190418","article-title":"Biology and therapeutic potential of interleukin-10","volume":"217","author":"Saraiva","year":"2020","journal-title":"J Exp Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1136\/thx.51.2.143","article-title":"Interleukin 10 (Il-10) regulation of tumour necrosis factor alpha (Tnf-alpha) from human alveolar macrophages and peripheral blood monocytes","volume":"51","author":"Armstrong","year":"1996","journal-title":"Thorax"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/nri2711","article-title":"The regulation of il-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41375\u2013021-01217\u20131","article-title":"Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia","volume":"35","author":"Rivas","year":"2021","journal-title":"Leukemia"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.140644","article-title":"Tregs facilitate obesity and insulin resistance via a blimp-1\/il-10 axis","volume":"6","author":"Beppu","year":"2021","journal-title":"JCI Insight"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/S0167\u20135699(05)80015\u20135","article-title":"The role of il-10 in crossregulation of th1 and th2 responses","volume":"12","author":"Mosmann","year":"1991","journal-title":"Immunol Today"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521\u20134141(199801)28:01<359::AID-IMMU359>3.0.CO;2\u20134","article-title":"Il-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages","volume":"28","author":"Allavena","year":"1998","journal-title":"Eur J Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.2.741","article-title":"High level il-12 production by murine dendritic cells: upregulation via mhc class ii and cd40 molecules and downregulation by il-4 and il-10","volume":"184","author":"Koch","year":"1996","journal-title":"J Exp Med"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2014.12.009","article-title":"Suppression of antigen presentation by il-10","volume":"34","author":"Mittal","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100284","article-title":"Mice lacking endogenous il-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of th1\/th17 but a decrease in regulatory T cells","volume":"186","author":"Carter","year":"2011","journal-title":"J Immunol"},{"key":"B99","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.162.3.1723","article-title":"A transgenic model to analyze the immunoregulatory role of il-10 secreted by antigen-presenting cells","volume":"162","author":"Groux","year":"1999","journal-title":"J Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v98.7.2143","article-title":"Interleukin-10 promotes the maintenance of antitumor cd8(+) T-cell effector function in situ","volume":"98","author":"Fujii","year":"2001","journal-title":"Blood"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1158\/0008\u20135472.CAN-12\u20130721","article-title":"Il-10 directly activates and expands tumor-resident cd8(+) T cells without de novo infiltration from secondary lymphoid organs","volume":"72","author":"Emmerich","year":"2012","journal-title":"Cancer Res"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2227","article-title":"The composition and signaling of the il-35 receptor are unconventional","volume":"13","author":"Collison","year":"2012","journal-title":"Nat Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/imm.13044","article-title":"Interleukin-35 in immune-related diseases: protection or destruction","volume":"157","author":"Zhang","year":"2019","journal-title":"Immunology"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117663","article-title":"Jak\/stat signaling is involved in il-35-induced inhibition of hepatitis B virus antigen-specific cytotoxic T cell exhaustion in chronic hepatitis B","volume":"252","author":"Dong","year":"2020","journal-title":"Life Sci"},{"key":"B105","doi-asserted-by":"publisher","first-page":"15709","DOI":"10.3390\/ijms232415709","article-title":"Current insight into the role of il-35 and its potential involvement in the pathogenesis and therapy of atopic dermatitis","volume":"23","author":"Zysk","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine il-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"B107","article-title":"Assessing the role of il-35 in colorectal cancer progression and prognosis","volume":"6","author":"Zeng","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202535","article-title":"Tumor-derived il-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis","volume":"190","author":"Wang","year":"2013","journal-title":"J Immunol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.01.013","article-title":"Interleukin-35 limits anti-tumor immunity","volume":"44","author":"Turnis","year":"2016","journal-title":"Immunity"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016295","article-title":"Il-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4049\/jimmunol.0903314","article-title":"The influence of excessive il-6 production in vivo on the development and function of foxp3+ Regulatory T cells","volume":"186","author":"Fujimoto","year":"2011","journal-title":"J Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200413","article-title":"Ifn-gamma production by allogeneic foxp3+ Regulatory T cells is essential for preventing experimental graft-versus-host disease","volume":"189","author":"Koenecke","year":"2012","journal-title":"J Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector th17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155517","article-title":"The imbalance of tnf and il-6 levels and foxp3 expression at the maternal-fetal interface is involved in adverse pregnancy outcomes in a susceptible murine model of congenital toxoplasmosis","volume":"143","author":"Sousa","year":"2021","journal-title":"Cytokine"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.11.6725","article-title":"Cutting edge: regulatory T cells induce cd4+Cd25-foxp3- T cells or are self-induced to become th17 cells in the absence of exogenous tgf-beta","volume":"178","author":"Xu","year":"2007","journal-title":"J Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2023.213496","article-title":"Regulatory T cell intravitreal delivery using hyaluronan methylcellulose hydrogel improves therapeutic efficacy in experimental autoimmune uveitis","volume":"151","author":"Zhang","year":"2023","journal-title":"Biomater Adv"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201040391","article-title":"Il-6: regulator of treg\/th17 balance","volume":"40","author":"Kimura","year":"2010","journal-title":"Eur J Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/nature07036","article-title":"Induction and effector functions of T(H)17 cells","volume":"453","author":"Bettelli","year":"2008","journal-title":"Nature"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.07.018","article-title":"Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction","volume":"29","author":"Ogura","year":"2008","journal-title":"Immunity"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C600321200","article-title":"Stat3 regulates cytokine-mediated generation of inflammatory helper T cells","volume":"282","author":"Yang","year":"2007","journal-title":"J Biol Chem"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1315862110","article-title":"Stat3 activation in response to il-6 is prolonged by the binding of il-6 receptor to egf receptor","volume":"110","author":"Wang","year":"2013","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202048794","article-title":"Transcriptional and posttranslational regulation of th17\/treg balance in health and disease","volume":"51","author":"Zhang","year":"2021","journal-title":"Eur J Immunol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2009.10.014","article-title":"An epigenetic switch involving nf-kappab, lin28, let-7 microrna, and il6 links inflammation to cell transformation","volume":"139","author":"Iliopoulos","year":"2009","journal-title":"Cell"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1158\/1078\u20130432.CCR-12\u20132177","article-title":"Human regulatory T cells do not suppress the antitumor immunity in the bone marrow: A role for bone marrow stromal cells in neutralizing regulatory T cells","volume":"19","author":"Guichelaar","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.223","article-title":"Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives","volume":"30","author":"Lonial","year":"2016","journal-title":"Leukemia"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20132141.2010.08533.x","article-title":"Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma","volume":"152","author":"Hunsucker","year":"2011","journal-title":"Br J Haematol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.4.2277","article-title":"Retinoic acid increases foxp3+ Regulatory T cells and inhibits development of th17 cells by enhancing tgf-beta-driven smad3 signaling and inhibiting il-6 and il-23 receptor expression","volume":"181","author":"Xiao","year":"2008","journal-title":"J Immunol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005\u201311-4567","article-title":"Tnf downmodulates the function of human cd4+Cd25hi T-regulatory cells","volume":"108","author":"Valencia","year":"2006","journal-title":"Blood"},{"key":"B129","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/jmcb\/mjs063","article-title":"Tnf-alpha impairs differentiation and function of tgf-beta-induced treg cells in autoimmune diseases through akt and smad3 signaling pathway","volume":"5","author":"Zhang","year":"2013","journal-title":"J Mol Cell Biol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.1.154","article-title":"Interaction of tnf with tnf receptor type 2 promotes expansion and function of mouse cd4+Cd25+ T regulatory cells","volume":"179","author":"Chen","year":"2007","journal-title":"J Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201041205","article-title":"Tnf optimally activatives regulatory T cells by inducing tnf receptor superfamily members tnfr2, 4\u20131bb and ox40","volume":"41","author":"Hamano","year":"2011","journal-title":"Eur J Immunol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202659","article-title":"Tnfr2 is critical for the stabilization of the cd4+ Foxp3+ Regulatory T cell phenotype in the inflammatory environment","volume":"190","author":"Chen","year":"2013","journal-title":"J Immunol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2849","article-title":"Costimulation via the tumor-necrosis factor receptor superfamily couples tcr signal strength to the thymic differentiation of regulatory T cells","volume":"15","author":"Mahmud","year":"2014","journal-title":"Nat Immunol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1038\/ncomms4199","article-title":"Tnf-alpha blockade induces il-10 expression in human cd4+ T cells","volume":"5","author":"Evans","year":"2014","journal-title":"Nat Commun"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/505432","article-title":"In crohn\u2019s disease, anti-tnf-alpha treatment changes the balance between mucosal il-17, foxp3, and cd4 cells","volume":"2012","author":"Holtta","year":"2012","journal-title":"ISRN Gastroenterol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1007\/s40262\u2013021-01057\u20133","article-title":"Infliximab treatment does not lead to full tnf-alpha inhibition: A target-mediated drug disposition model","volume":"61","author":"Ternant","year":"2022","journal-title":"Clin Pharmacokinet"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3085","article-title":"Phosphorylation of foxp3 controls regulatory T cell function and is inhibited by tnf-alpha in rheumatoid arthritis","volume":"19","author":"Nie","year":"2013","journal-title":"Nat Med"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e10450","article-title":"Implications of regulatory T cells in anti-cancer immunity: from pathogenesis to therapeutics","volume":"8","author":"Dwivedi","year":"2022","journal-title":"Heliyon"},{"key":"B139","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12943\u2013023-01714\u20130","article-title":"Regulatory cells and the effect of cancer immunotherapy","volume":"22","author":"Iglesias-Escudero","year":"2023","journal-title":"Mol Cancer"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjad067","article-title":"Blockade of tnf-alpha\/tnfr2 signalling suppresses colorectal cancer and enhances the efficacy of anti-pd1 immunotherapy by decreasing ccr8+ T regulatory cells","author":"Guo","year":"2023","journal-title":"J Mol Cell Biol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33873","article-title":"The effects of tnf-alpha\/tnfr2 in regulatory T cells on the microenvironment and progression of gastric cancer","volume":"150","author":"Qu","year":"2022","journal-title":"Int J Cancer"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.23.021704.115611","article-title":"The B7 family revisited","volume":"23","author":"Greenwald","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1158\/1078\u20130432.CCR-07\u20131030","article-title":"The B7 family and cancer therapy: costimulation and coinhibition","volume":"13","author":"Zang","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B144","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13045\u2013022-01325\u20130","article-title":"Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts","volume":"15","author":"Wang","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-year survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N Engl J Med"},{"key":"B146","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41419-023-06391-x","article-title":"Anti-ctla-4 nanobody as a promising approach in cancer immunotherapy","volume":"15","author":"Babamohamadi","year":"2024","journal-title":"Cell Death Dis"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of cd80 and cd86: A molecular basis for the cell-extrinsic function of ctla-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1038\/s41577\u2013020-0306\u20135","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20141030","article-title":"Deletion of ctla-4 on regulatory T cells during adulthood leads to resistance to autoimmunity","volume":"212","author":"Paterson","year":"2015","journal-title":"J Exp Med"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0910341107","article-title":"Dual function of ctla-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity","volume":"107","author":"Jain","year":"2010","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1198365","article-title":"Current understanding of ctla-4: from mechanism to autoimmune diseases","volume":"14","author":"Hossen","year":"2023","journal-title":"Front Immunol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.11.089946","article-title":"Ctla-4 blockade reverses the foxp3+ T-regulatory-cell suppression of anti-tuberculosis T-cell effector responses","author":"Shao","year":"2020","journal-title":"bioRxiV"},{"key":"B153","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1186\/s12879\u2013021-06730\u20133","article-title":"Impact of immune checkpoint molecules on foxp3(+) treg cells and related cytokines in patients with acute and chronic brucellosis","volume":"21","author":"Sun","year":"2021","journal-title":"BMC Infect Dis"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013496","article-title":"Abatacept is useful in autoimmune cytopenia with immunopathologic manifestations caused by ctla-4 defects","volume":"139","author":"Dhunputh","year":"2022","journal-title":"Blood"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12600","article-title":"High ctla-4 expression on th17 cells results in increased sensitivity to ctla-4 coinhibition and resistance to belatacept","volume":"14","author":"Krummey","year":"2014","journal-title":"Am J Transplant"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3390\/cancers13061440","article-title":"Ctla-4 in regulatory T cells for cancer immunotherapy","volume":"13","author":"Sobhani","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201362","article-title":"The B7-independent isoform of ctla-4 functions to regulate autoimmune diabetes","volume":"190","author":"Stumpf","year":"2013","journal-title":"J Immunol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxg061","article-title":"Targeted engagement of ctla-4 prevents autoimmune thyroiditis","volume":"15","author":"Vasu","year":"2003","journal-title":"Int Immunol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/s10038\u2013018-0414\u20132","article-title":"The synergic effects of ctla-4\/foxp3-related genotypes and chromosomal aberrations on the risk of recurrent spontaneous abortion among a Chinese han population","volume":"63","author":"Fan","year":"2018","journal-title":"J Hum Genet"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/s0165\u20135728(02)00274\u20136","article-title":"Ctla4 dimorphisms and the multiple sclerosis phenotype","volume":"131","author":"Masterman","year":"2002","journal-title":"J Neuroimmunol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.21.9543\u20139553.2005","article-title":"Ctla-4 and pd-1 receptors inhibit T-cell activation by distinct mechanisms","volume":"25","author":"Parry","year":"2005","journal-title":"Mol Cell Biol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1155778","article-title":"Bispecific antibodies targeting ctla-4: game-changer troopers in cancer immunotherapy","volume":"14","author":"Farhangnia","year":"2023","journal-title":"Front Immunol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1163633","article-title":"The role of pd-1 signaling in health and immune-related diseases","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02374","article-title":"Inhibitory receptors and pathways of lymphocytes: the role of pd-1 in treg development and their involvement in autoimmunity onset and cancer progression","volume":"9","author":"Gianchecchi","year":"2018","journal-title":"Front Immunol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571\u2013022-00601\u20139","article-title":"Mechanisms regulating pd-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics","volume":"19","author":"Yamaguchi","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2021.101480","article-title":"Emerging concepts in pd-1 checkpoint biology","volume":"52","author":"Pauken","year":"2021","journal-title":"Semin Immunol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.85935","article-title":"Pd-1 marks dysfunctional regulatory T cells in Malignant gliomas","volume":"1","author":"Lowther","year":"2016","journal-title":"JCI Insight"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20182232","article-title":"Pd-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance","volume":"218","author":"Tan","year":"2021","journal-title":"J Exp Med"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1038\/s41590\u2013020-0769\u20133","article-title":"The pd-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of pd-1 blockade therapies","volume":"21","author":"Kumagai","year":"2020","journal-title":"Nat Immunol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021\u2013004037","article-title":"Gallic acid induces T-helper-1-like T(Reg) cells and strengthens immune checkpoint blockade efficacy","volume":"10","author":"Deng","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2496","article-title":"The receptor pd-1 controls follicular regulatory T cells in the lymph nodes and blood","volume":"14","author":"Sage","year":"2013","journal-title":"Nat Immunol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020\u2013000967","article-title":"Neuropilin-1: A checkpoint target with unique implications for cancer immunology and immunotherapy","volume":"8","author":"Chuckran","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00125","article-title":"Neuropilin-1 as therapeutic target for Malignant melanoma","volume":"5","author":"Graziani","year":"2015","journal-title":"Front Oncol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S409336","article-title":"Overexpression of nrp1 is associated with poor prognosis via accelerating immunosuppression in head and neck squamous cell carcinoma","volume":"16","author":"Yang","year":"2023","journal-title":"Int J Gen Med"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1158\/1078\u20130432.CCR-17\u20131350","article-title":"Novel effector phenotype of tim-3(+) regulatory T cells leads to enhanced suppressive function in head and neck cancer patients","volume":"24","author":"Liu","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.16.00030","article-title":"Programmed cell death 1 (Pd-1) ligand (Pd-L1) expression in solid tumors as a predictive biomarker of benefit from pd-1\/pd-L1 axis inhibitors: A systematic review and meta-analysis","volume":"1","author":"Khunger","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106214","article-title":"Predictive effect of pd-L1 expression for immune checkpoint inhibitor (Pd-1\/pd-L1 inhibitors) treatment for non-small cell lung cancer: A meta-analysis","volume":"80","author":"Zhang","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1075813","article-title":"The emerging role of regulatory cell-based therapy in autoimmune disease","volume":"13","author":"Ghobadinezhad","year":"2022","journal-title":"Front Immunol"},{"key":"B179","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.coi.2015.09.002","article-title":"Targeting treg signaling for the treatment of autoimmune diseases","volume":"37","author":"Spence","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1038\/s41586\u2013023-06300\u20134","article-title":"Co-transplantation of autologous T(Reg) cells in a cell therapy for Parkinson\u2019s disease","volume":"619","author":"Park","year":"2023","journal-title":"Nature"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018\u201307-863233","article-title":"Targeting sirt-1 controls gvhd by inhibiting T-cell allo-response and promoting treg stability in mice","volume":"133","author":"Daenthanasanmak","year":"2019","journal-title":"Blood"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1244298","article-title":"Regulating the regulatory T cells as cell therapies in autoimmunity and cancer","volume":"10","author":"Hosseinalizadeh","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2009.080987","article-title":"Surveillance of antigen-presenting cells by cd4+ Cd25+ Regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications","volume":"174","author":"Andre","year":"2009","journal-title":"Am J Pathol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2013.2","article-title":"Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy","volume":"10","author":"Pedroza-Pacheco","year":"2013","journal-title":"Cell Mol Immunol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.0c00657","article-title":"Proteomic data analysis for differential profiling of the autoimmune diseases sle, ra, ss, and anca-associated vasculitis","volume":"20","author":"Ohlsson","year":"2021","journal-title":"J Proteome Res"},{"key":"B186","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.15537\/smj.2023.44.12.20230818","article-title":"Comment on: autoimmune diseases and their prevalence in Saudi Arabian patients with type 1 diabetes mellitus","volume":"44","author":"Alsaeed","year":"2023","journal-title":"Saudi Med J"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1103375","article-title":"Issues occupying our minds: nomenclature of autoimmune blistering diseases requires updating, pemphigus vulgaris propensity to affect areas adjacent to natural body orifices unifies seemingly diverse clinical features of this disease","volume":"13","author":"Dmochowski","year":"2022","journal-title":"Front Immunol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.860880","article-title":"Hashimoto thyroiditis, anti-parietal cell antibodies: associations with autoimmune diseases and Malignancies","volume":"13","author":"Boutzios","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B189","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nrgastro.2012.167","article-title":"Ibd: regulatory T-cell therapy is a safe and well-tolerated potential approach for treating refractory Crohn\u2019s disease","volume":"9","author":"McLarnon","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019\u2013319850","article-title":"Regulatory T-cell therapy in Crohn\u2019s disease: challenges and advances","volume":"69","author":"Clough","year":"2020","journal-title":"Gut"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181107","article-title":"Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of il-2 in the blood of patients undergoing therapy","volume":"12","author":"Diestelhorst","year":"2017","journal-title":"PloS One"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1007\/s00296\u2013013-2795-z","article-title":"The beneficial effect of leflunomide on systemic lupus erythematosus: the role of tregs repopulation?: comment on: leflunomide: friend or foe for systemic lupus erythematosus","volume":"33","author":"Shin","year":"2013","journal-title":"Rheumatol Int"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1007\/s10753\u2013019-00980\u20139","article-title":"Silymarin restores regulatory T cells (Tregs) function in multiple sclerosis (Ms) patients in vitro","volume":"42","author":"Shariati","year":"2019","journal-title":"Inflammation"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2008.11.015","article-title":"The role of foxp3+Cd4+Cd25hi tregs in the pathogenesis of myasthenia gravis","volume":"122","author":"Zhang","year":"2009","journal-title":"Immunol Lett"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ19\u20130307","article-title":"The proportion of peripheral blood tregs among the cd4+ T cells of autoimmune thyroid disease patients: A meta-analysis","volume":"67","author":"Chen","year":"2020","journal-title":"Endocr J"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003372","article-title":"Interplay between tnf and regulatory T cells in a tnf-driven murine model of arthritis","volume":"186","author":"Biton","year":"2011","journal-title":"J Immunol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2011.07.043","article-title":"Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis","volume":"585","author":"Chavele","year":"2011","journal-title":"FEBS Lett"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.750542","article-title":"Regulatory T cells: regulation of identity and function","volume":"12","author":"Grover","year":"2021","journal-title":"Front Immunol"},{"key":"B199","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.3390\/cells10081847","article-title":"Translating treg therapy for inflammatory bowel disease in humanized mice","volume":"10","author":"Negi","year":"2021","journal-title":"Cells"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1164761","article-title":"Commentary: T cell metabolism: A new perspective on th17\/treg cell imbalance in systemic lupus erythematosus","volume":"14","author":"Jin","year":"2023","journal-title":"Front Immunol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2017.11.026","article-title":"Autoimmune thyroid diseases and th17\/treg lymphocytes","volume":"192","author":"Shao","year":"2018","journal-title":"Life Sci"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1002\/art.40737","article-title":"Adoptive treg cell therapy in a patient with systemic lupus erythematosus","volume":"71","author":"Dall\u2019Era","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8575407","article-title":"Efficient therapeutic function and mechanisms of human polyclonal cd8(+)Cd103(+)Foxp3(+) regulatory T cells on collagen-induced arthritis in mice","volume":"2019","author":"Sun","year":"2019","journal-title":"J Immunol Res"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1621280114","article-title":"Ccr8(+)Foxp3(+) T(Reg) cells as master drivers of immune regulation","volume":"114","author":"Barsheshet","year":"2017","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B205","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jaut.2015.09.005","article-title":"Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells","volume":"67","author":"Aricha","year":"2016","journal-title":"J Autoimmun"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.126471","article-title":"Stem cell-derived tissue-associated regulatory T cells suppress the activity of pathogenic cells in autoimmune diabetes","volume":"4","author":"Haque","year":"2019","journal-title":"JCI Insight"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1002\/mrd.23404","article-title":"Adoptive transfers of cd4(+) cd25(+) tregs partially alleviate mouse premature ovarian insufficiency","volume":"87","author":"Liu","year":"2020","journal-title":"Mol Reprod Dev"},{"key":"B208","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbrc.2019.02.147","article-title":"Adoptive transfer of regulatory T cells stimulated by allogeneic hepatic stellate cells mitigates liver injury in mice with concanavalin a-induced autoimmune hepatitis","volume":"512","author":"Huang","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9064073","article-title":"Adoptive transfers of cd4(+)Cd25(+) tregs raise foxp3 expression and alleviate mouse enteritis","volume":"2018","author":"Wang","year":"2018","journal-title":"BioMed Res Int"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2018.0113","article-title":"Enhancement of graft-versus-host disease control efficacy by adoptive transfer of type 1 regulatory T cells in bone marrow transplant model","volume":"28","author":"Jeon","year":"2019","journal-title":"Stem Cells Dev"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3734","article-title":"Regulatory T cells for minimising immune suppression in kidney transplantation: phase I\/iia clinical trial","volume":"371","author":"Roemhild","year":"2020","journal-title":"BMJ"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.115050","article-title":"Emerging strategies to bypass transplant rejection via biomaterial-assisted immunoengineering: insights from islets and beyond","volume":"200","author":"Abbaszadeh","year":"2023","journal-title":"Adv Drug Delivery Rev"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2016.147","article-title":"Adenosine selectively depletes alloreactive T cells to prevent gvhd while conserving immunity to viruses and leukemia","volume":"24","author":"Whitehill","year":"2016","journal-title":"Mol Ther"},{"key":"B214","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3390\/cells12121609","article-title":"Pd-L1\u2019s role in preventing alloreactive T cell responses following hematopoietic and organ transplant","volume":"12","author":"Handelsman","year":"2023","journal-title":"Cells"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03061","article-title":"Regulation of gvhd and gvl activity via pd-L1 interaction with pd-1 and cd80","volume":"9","author":"Cassady","year":"2018","journal-title":"Front Immunol"},{"key":"B216","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41423\u2013021-00742\u20134","article-title":"Tissue-specific tregs in cancer metastasis: opportunities for precision immunotherapy","volume":"19","author":"Huppert","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00163","article-title":"The role of regulatory T cells in the biology of graft versus host disease","volume":"4","author":"Beres","year":"2013","journal-title":"Front Immunol"},{"key":"B218","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/biomedicines10020287","article-title":"Car-T regulatory (Car-treg) cells: engineering and applications","volume":"10","author":"Arjomandnejad","year":"2022","journal-title":"Biomedicines"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.686439","article-title":"Precision engineering of an anti-hla-A2 chimeric antigen receptor in regulatory T cells for transplant immune tolerance","volume":"12","author":"Muller","year":"2021","journal-title":"Front Immunol"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1172\/JCI82771","article-title":"Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor","volume":"126","author":"MacDonald","year":"2016","journal-title":"J Clin Invest"},{"key":"B221","doi-asserted-by":"publisher","first-page":"14114","DOI":"10.3390\/ijms241814114","article-title":"The role of regulatory T cells in cancer treatment resistance","volume":"24","author":"Dabrowska","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B222","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/clinpract13010003","article-title":"The role of immune checkpoint inhibitors in cancer therapy","volume":"13","author":"BaSudan","year":"2022","journal-title":"Clin Pract"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v118.21.lba-2.bld0076_p1_lba-2","article-title":"Local treg immunomodulation cures metastatic lymphoma including cns sites","volume":"118","author":"Marabelle","year":"2011","journal-title":"Blood"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1038\/s41586\u2013019-1215\u20132","article-title":"Targeting the cbm complex causes T(Reg) cells to prime tumours for immune checkpoint therapy","volume":"570","author":"Di Pilato","year":"2019","journal-title":"Nature"},{"key":"B225","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.immuni.2019.06.017","article-title":"Treg cells promote the srebp1-dependent metabolic fitness of tumor-promoting macrophages via repression of cd8(+) T cell-derived interferon-gamma","volume":"51","author":"Liu","year":"2019","journal-title":"Immunity"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1158\/2326\u20136066.CIR-14\u20130160","article-title":"Chemokines in cancer","volume":"2","author":"Chow","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"B227","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12943\u2013020-01234\u20131","article-title":"Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects","volume":"19","author":"Li","year":"2020","journal-title":"Mol Cancer"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1158\/2326\u20136066.CIR-18\u20130751","article-title":"Ccr4 blockade depletes regulatory T cells and prolongs survival in a canine model of bladder cancer","volume":"7","author":"Maeda","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B229","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41590\u2013019-0589\u20135","article-title":"Cd36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors","volume":"21","author":"Wang","year":"2020","journal-title":"Nat Immunol"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.04.019","article-title":"The tnf receptor superfamily in co-stimulating and co-inhibitory responses","volume":"44","author":"Ward-Kavanagh","year":"2016","journal-title":"Immunity"},{"key":"B231","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40259\u2013022-00573\u20133","article-title":"Targeting co-stimulatory receptors of the tnf superfamily for cancer immunotherapy","volume":"37","author":"Muller","year":"2023","journal-title":"BioDrugs"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1005582","article-title":"Membrane-bound il-2 improves the expansion, survival, and phenotype of car tregs and confers resistance to calcineurin inhibitors","volume":"13","author":"Kremer","year":"2022","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1387975\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T07:52:50Z","timestamp":1741161170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1387975\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,13]]},"references-count":232,"alternative-id":["10.3389\/fimmu.2024.1387975"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1387975","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,13]]},"article-number":"1387975"}}